News

  • 6 December 2011

    Takeda unveils global vaccine business plans

    Japan-based pharmaceutical company Takeda has revealed plans to launch a vaccine business division (VBD) in order to strengthen the company’s plans for a global expansion of its vaccine unit.

  • 5 December 2011

    Eisai opens US cancer facility

    Japan-based pharmaceutical company Eisai has opened a new facility in Cambridge, Massachusetts, US, to house its H3 Biomedicine unit.

  • 4 December 2011

    Teva to enter Lipitor generic market

    Teva Pharmaceutical has been given tentative approval for its generic version of Pfizer's blockbuster Lipitor by the US Food and Drug Administration (FDA), allowing Teva to enter the lucrative market...

  • 4 December 2011

    Pfizer acquires Excaliard Pharmaceuticals

    Pfizer has completed the acquisition of Excaliard Pharmaceuticals, a US biopharma company focused on developing drugs for the treatment of skin fibrosis.

  • 30 November 2011

    Latent tuberculosis vaccine enters clinical testing

    Non-profit product development partnership Aeras has announced the start of a Phase I clinical trial of a new candidate tuberculosis vaccine, designed specifically to protect against the latent form of...

Go Top